Enzo Biochem Inc (N:ENZ)

Business Focus: Medical & Diagnostic Laboratories

Latest 10 SEC filings (by transaction date) for ENZ within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET December 6th, 2022
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Nov 28/22 Nov 23/22 Erfanian Hamid Direct Ownership Stock Option (to acquire Common Stock) A - Grant, award or other under Rule 16b-3(d) 300,000  
Nov 28/22 Nov 23/22 Erfanian Hamid Direct Ownership Common Stock, $0.01 Par Value P - Open market or private purchase 100,000 $1.97
Nov 28/22 Nov 23/22 Cannon Kara Direct Ownership Stock Option (to acquire Common Stock) A - Grant, award or other under Rule 16b-3(d) 200,000  
Nov 15/22 Nov 15/22 Eckert Patricia Direct Ownership Stock Option (to acquire Common Stock) Form 3 : Initial Statement of Beneficial Ownership of Securities    
Nov 15/22 Nov 15/22 Eckert Patricia Direct Ownership Stock Option (to acquire Common Stock) Form 3 : Initial Statement of Beneficial Ownership of Securities    
Nov 15/22 Nov 15/22 Eckert Patricia Direct Ownership Stock Option (to acquire Common Stock) Form 3 : Initial Statement of Beneficial Ownership of Securities    
Nov 15/22 Nov 15/22 Eckert Patricia Indirect Ownership Common Stock, $0.01 Par Value Form 3 : Initial Statement of Beneficial Ownership of Securities    
Jul 19/22 Jul 15/22 Cannon Kara Direct Ownership Common Stock, $0.01 Par Value P - Open market or private purchase 2,500 $2.42
Jul 14/22 Jul 12/22 Tagliaferri Mary Direct Ownership Common Stock, $0.01 Par Value A - Grant, award or other under Rule 16b-3(d) 41,666  
Jul 14/22 Jul 12/22 Walters Ian B. Direct Ownership Common Stock, $0.01 Par Value A - Grant, award or other under Rule 16b-3(d) 41,666  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for ENZ within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET December 6th, 2022
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Nov 28/22 Nov 23/22 Erfanian Hamid Direct Ownership Stock Option (to acquire Common Stock) A - Grant, award or other under Rule 16b-3(d) 300,000  
Nov 28/22 Nov 23/22 Erfanian Hamid Direct Ownership Common Stock, $0.01 Par Value P - Open market or private purchase 100,000 $1.97
Nov 28/22 Nov 23/22 Cannon Kara Direct Ownership Stock Option (to acquire Common Stock) A - Grant, award or other under Rule 16b-3(d) 200,000  
Nov 15/22 Nov 15/22 Eckert Patricia Direct Ownership Stock Option (to acquire Common Stock) Form 3 : Initial Statement of Beneficial Ownership of Securities    
Nov 15/22 Nov 15/22 Eckert Patricia Direct Ownership Stock Option (to acquire Common Stock) Form 3 : Initial Statement of Beneficial Ownership of Securities    
Nov 15/22 Nov 15/22 Eckert Patricia Direct Ownership Stock Option (to acquire Common Stock) Form 3 : Initial Statement of Beneficial Ownership of Securities    
Nov 15/22 Nov 15/22 Eckert Patricia Indirect Ownership Common Stock, $0.01 Par Value Form 3 : Initial Statement of Beneficial Ownership of Securities    
Jul 19/22 Jul 15/22 Cannon Kara Direct Ownership Common Stock, $0.01 Par Value P - Open market or private purchase 2,500 $2.42
Jul 14/22 Jul 12/22 Tagliaferri Mary Direct Ownership Common Stock, $0.01 Par Value A - Grant, award or other under Rule 16b-3(d) 41,666  
Jul 14/22 Jul 12/22 Walters Ian B. Direct Ownership Common Stock, $0.01 Par Value A - Grant, award or other under Rule 16b-3(d) 41,666  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $ENZ

Competitors

Competitors with Recent Insider Filings
Biodesix (OQ:BDSX)
Fulgent Genetics (OQ:FLGT)
23andMe Holding Co. (OQ:ME)

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.